SEC Form 4 · accession 0001493152-26-028754
Insight Molecular Diagnostics Inc. · IMDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew J. Last
Director
Period of report
Jun 11, 2026
Accepted (ET)
Jun 15, 2026 · 6:22 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001642380
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, no par valueF1 | Jun 11, 2026 | A | 26,943 | $0.00 | A | 66,452 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Restricted Stock Units shall vest on the date of the next annual meeting of shareholders, subject to the Reporting Person's continued service from the date of grant until the vesting date.